Ginkgo biloba extract 761 (Rokan)

Subscribe to Selected New Research on Ginkgo biloba extract 761

297 relevant articles (61 outcomes, 94 trials/studies) found for this Bio-Agent

Description: extract from Ginkgo leaves in which terpene trilactones (ginkgolides) are enriched to 6% and allergenic ginkgolic acids removed down to a few ppm; used in treatment of peripheral vascular disease & cerebral insufficiency; is an ingredient of Ginkor

Also Known As:

Rokan; EGb761; EGb 761; EGb-761; GBE 761; GBE 761 ONC; GBE-761; Tanakan; Tebofortran; Tebokan; Tebonin

Relationship Network

Bio-Agent Context: Research Results

Complex Mixtures: 314

Biological Products

Plant Preparations: 253

Plant Extracts: 276

Ginkgo biloba extract 761: 297

Pharmaceutical Preparations

Plant Extracts: 276

Ginkgo biloba extract 761: 297

Experts

1.	Drieu, K: 5 articles (06/2003 - 01/2000)
2.	Hoerr, R: 4 articles (09/2007 - 01/2002)
3.	Kieser, M: 4 articles (09/2007 - 07/2000)
4.	Drieu, Katy: 4 articles (01/2006 - 09/2002)
5.	Luo, Yuan: 3 articles (11/2007 - 08/2003)
6.	Christen, Yves: 3 articles (11/2007 - 07/2007)
7.	Le Bars, P L: 3 articles (06/2003 - 07/2000)
8.	Ustün, Hüseyin: 2 articles (01/2008 - 09/2003)
9.	Xu, Yanan: 2 articles (11/2007 - 08/2007)
10.	Wu, Wei-Kang: 2 articles (01/2007 - 01/2007)

Related Diseases

1.	Dementia (Dementias) 01/01/1995 - "Recent studies in which EGb 761 demonstrated therapeutic effects in the treatment of dementia have earned EGb the approval of the German BGA (Bundesgesundheit Amt) for use in the treatment of dementia." 01/01/2007 - "This trial was undertaken to assess the efficacy of EGb 761 in mild to moderate dementia with neuropsychiatric features. " 06/01/2003 - "Taking together, there is experimental evidence for a neuroprotective effect of EGb 761 that agrees with clinical studies showing the efficacy of an oral treatment in patients with mild and moderate dementia." 01/01/2006 - "Probable efficacy of long-term tanakan treatment in prevention of dementia is discussed." 11/01/1997 - "Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type." Order ALL the reference details at left...
2.	Alzheimer Disease (Alzheimer's Disease) 11/14/2006 - "A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint." 03/27/2006 - "Research in my laboratory focuses on understanding mechanisms of action of the components of the herbal extract EGb 761 in protection against Alzheimer's disease. " 07/01/1999 - "The future of EGb 761 is undoubtedly in the promise in slowing the progression of Alzheimer's disease. " 01/15/2009 - "Several clinical trials have reported beneficial effects of the Ginkgo biloba extract EGb761 in the prevention and therapy of cognitive disorders including Alzheimer's disease (AD). " 08/01/2008 - "GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. " Order ALL the reference details at left...
3.	Reperfusion Injury 09/01/2001 - "[Protective effects of a Ginkgo biloba extract (EGb 761) on ischemia-reperfusion injury]" 06/01/1994 - "These results indicate that EGb 761 protects against cardiac ischemia-reperfusion injury and suggest that the protective effects of EGb 761 depend on its antioxidant properties." 01/01/2002 - "BACKGROUND/AIMS: The aim of this study was to determine the effect of Ginkgo Biloba (EGb 761) on reperfusion injury of the small bowel. " 06/01/1994 - "In the present study, effects of EGb 761 on cardiac ischemia-reperfusion injury were investigated from the point of view of recovery of mechanical function as well as the endogenous antioxidant status of ascorbate. " 12/01/2008 - "These findings suggest that antioxidant molecules such as NAC and EGb761 may be useful in preventing postischaemic reperfusion injury in hepatic tissue." Order ALL the reference details at left...
4.	Brain Ischemia (Cerebral Ischemia) 01/01/1998 - "Preliminary EEG study of protective effects of Tebonin in transient global cerebral ischemia in rats." 11/01/2008 - "Our findings suggest that EGb761 favor clearance of Abeta via regulating the expression of RAGE and LRP-1 during brain ischemia. " 01/01/2003 - "In this study, gerbils were fed standard chow with or without EGb761 (100 mg/kg/day, i.g.) prior to cerebral ischemia for 1 week. " 01/01/2003 - "The present study was designed to evaluate the neuroprotective effects of Ginkgo biloba leaf extract (EGb761) in male gerbils subjected to focal cerebral ischemia produced by permanent occlusion of the right middle cerebral artery. " 01/01/2009 - "A standardized extract of Gingko biloba, EGb 761, has been shown to exert a neuroprotective effect against permanent and transient focal cerebral ischemia. " Order ALL the reference details at left...
5.	Tinnitus 01/01/2009 - "It was shown that monotherapy with tanakan effectively improved the hearing function and had the most pronounced beneficial effect on subjective tinnitus. " 05/01/2002 - "OBJECTIVE: The objective of the present study in 60 patients with chronic tinnitus aurium was to confirm the efficacy of oral treatment with 2 x 80 mg Ginkgo special extract EGb 761 per day subsequent to 10-day EGb 761 infusion treatment. " 05/01/2002 - "The efficacy of Ginkgo special extract EGb 761 in patients with tinnitus." 01/11/2001 - "In a systematic search of the literature 19 clinical trials investigating the effects of tinnitus treatment with Ginkgo biloba special extract EGb 761 were identified and evaluated. " 05/01/2002 - "METHODS: Patients with chronic tinnitus aurium underwent 10 days of in-patient infusion treatment with 200 mg/day EGb 761, after which they were randomized to double-blind, oral out-patient treatment with either 2 x 80 mg/day EGb 761 or placebo, given over a scheduled treatment period of 12 weeks. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Ginkgo biloba extract 761 (Rokan)
2.	donepezil (Aricept)
3.	Tacrine (Cognex)
4.	rivastigmine (Exelon)
5.	Free Radicals
6.	Oxygen
7.	Cholinesterase Inhibitors (Anticholinesterases)
8.	Superoxide Dismutase
9.	Hydrogen Peroxide (Hydroperoxide)
10.	Memantine (Namenda)

Related Therapies and Procedures

1.	Oral Administration
2.	Activities of Daily Living (ADL)
3.	Rejuvenation
4.	Injections
5.	Intravenous Injections

Best Treatments:
Research Summary Report
on Dementia

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 595 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>